Immunotherapy drug made available for some NHS patients with Hodgkin lymphoma

Grace Li                                                                                    September 15th, 2018                                    grace.li.piano@gmail.com
 

An immunotherapy drug will be made available to some patients with Hodgkin lymphoma on the NHS in England. Pembrolizumab (Keytruda) can now be used to treat patients who have not responded or stopped responding to standard treatment and aren’t able to have a stem cell transplant. A recommendation from the National Institute for Health and Care Excellence (NICE) said the drug will be made available via the Cancer Drugs Fund, while more data is collected on its effectiveness.

 

See original article at: https://www.cancerresearchuk.org/about-us/cancer-news/news-report/2018-0...

English(英文)
Tags: 
globalnews

*本網站所載內容只供一般資訊及參考之用。亞洲癌症研究基金會有限公司為註冊慈善机构,並非癌症醫療機構,因此我们不為患者提供任何有關癌症治療或臨床護理方面的建議。亞洲癌症研究基金會有限公司不提供、販賣、或收取任何保健產品、健康檢查、疾病篩查、疫苗以及類似醫療服務的費用。本網站所載資訊并非向使用者提供選擇医疗或癌症治療方案的建议。使用者須負責自行評估本網站所載的各項資料。針對個人診斷及醫療等方面的問題,本基金会建议您徵求醫生的專業意見。

登錄 X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
載入中